{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:31:20Z","timestamp":1790724680382,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,6,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Membrane Type 1 Matrix Metalloprotease (MT1-MMP) contributes to the invasive progression of breast cancers by degrading extracellular matrix tissues. Nucleoside diphosphate kinase, NME1\/NM23-H1, has been identified as a metastasis suppressor; however, its contribution to local invasion in breast cancer is not known. Here, we report that NME1 is up-regulated in ductal carcinoma in situ (DCIS) as compared to normal breast epithelial tissues. NME1 levels drop in microinvasive and invasive components of breast tumor cells relative to synchronous DCIS foci. We find a strong anti-correlation between NME1 and plasma membrane MT1-MMP levels in the invasive components of breast tumors, particularly in aggressive histological grade III and triple-negative breast cancers. Knockout of NME1 accelerates the invasive transition of breast tumors in the intraductal xenograft model. At the mechanistic level, we find that MT1-MMP, NME1 and dynamin-2, a GTPase known to require GTP production by NME1 for its membrane fission activity in the endocytic pathway, interact in clathrin-coated vesicles at the plasma membrane. Loss of NME1 function increases MT1-MMP surface levels by inhibiting endocytic clearance. As a consequence, the ECM degradation and invasive potentials of breast cancer cells are enhanced. This study identifies the down-modulation of NME1 as a potent driver of the in situ-to invasive transition during breast cancer progression.<\/jats:p>","DOI":"10.1038\/s41388-021-01826-1","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T04:03:34Z","timestamp":1621397014000},"page":"4019-4032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4360-9743","authenticated-orcid":false,"given":"Catalina","family":"Lodillinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-6307","authenticated-orcid":false,"given":"Laetitia","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Irondelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Pylypenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bonsang-Kitzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Calmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-760X","authenticated-orcid":false,"given":"Olivier","family":"De Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bi\u00e8che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Lise","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-0194","authenticated-orcid":false,"given":"Ana Maria","family":"Eij\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Houdusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-5771","authenticated-orcid":false,"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chavrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-5722","authenticated-orcid":false,"given":"Mathieu","family":"Boissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"1826_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","volume":"7","author":"CF Cowell","year":"2013","unstructured":"Cowell CF, Weigelt B, Sakr RA, Ng CK, Hicks J, King TA, et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol. 2013;7:859\u201369.","journal-title":"Mol Oncol"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1158\/0008-5472.CAN-12-0636","volume":"72","author":"S Lee","year":"2012","unstructured":"Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res. 2012;72:4574\u201386.","journal-title":"Cancer Res"},{"key":"1826_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/path.4840","volume":"241","author":"AK Casasent","year":"2017","unstructured":"Casasent AK, Edgerton M, Navin NE. Genome evolution in ductal carcinoma in situ: invasion of the clones. J Pathol. 2017;241:208\u201318.","journal-title":"J Pathol"},{"key":"1826_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/labinvest.2017.137","volume":"98","author":"M Boissan","year":"2018","unstructured":"Boissan M, Schlattner U, Lacombe ML. The NDPK\/NME superfamily: state of the art. Lab Invest. 2018;98:164\u201374.","journal-title":"Lab Invest"},{"key":"1826_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jnci\/80.3.200","volume":"80","author":"PS Steeg","year":"1988","unstructured":"Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200\u20134.","journal-title":"J Natl Cancer Inst"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/A:1023497924277","volume":"35","author":"T Ouatas","year":"2003","unstructured":"Ouatas T, Salerno M, Palmieri D, Steeg PS. Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr. 2003;35:73\u20139.","journal-title":"J Bioenerg Biomembr"},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1101\/gad.1096903","volume":"17","author":"V Dammai","year":"2003","unstructured":"Dammai V, Adryan B, Lavenburg KR, Hsu T. Drosophila awd, the homolog of human nm23, regulates FGF receptor levels and functions synergistically with shi\/dynamin during tracheal development. Genes Dev. 2003;17:2812\u201324.","journal-title":"Genes Dev"},{"key":"1826_CR8","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.1253768","volume":"344","author":"M Boissan","year":"2014","unstructured":"Boissan M, Montagnac G, Shen Q, Griparic L, Guitton J, Romao M, et al. Membrane trafficking. Nucleoside diphosphate kinases fuel dynamin superfamily proteins with GTP for membrane remodeling. Science. 2014;344:1510\u20135.","journal-title":"Science"},{"key":"1826_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.12688\/f1000research.11561.2","volume":"6","author":"D Zala","year":"2017","unstructured":"Zala D, Schlattner U, Desvignes T, Bobe J, Roux A, Chavrier P, et al. The advantage of channeling nucleotides for very processive functions. F1000Res. 2017;6:724.","journal-title":"F1000Res"},{"key":"1826_CR10","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/sj.onc.1210982","volume":"27","author":"L Szabova","year":"2008","unstructured":"Szabova L, Chrysovergis K, Yamada SS, Holmbeck K. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease. Oncogene. 2008;27:3274\u201381.","journal-title":"Oncogene"},{"key":"1826_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/onc.2015.87","volume":"35","author":"C Lodillinsky","year":"2016","unstructured":"Lodillinsky C, Infante E, Guichard A, Chaligne R, Fuhrmann L, Cyrta J, et al. p63\/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer. Oncogene. 2016;35:344\u201357.","journal-title":"Oncogene"},{"key":"1826_CR12","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1158\/0008-5472.CAN-10-4376","volume":"71","author":"JY Perentes","year":"2011","unstructured":"Perentes JY, Kirkpatrick ND, Nagano S, Smith EY, Shaver CM, Sgroi D, et al. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res. 2011;71:4527\u201338.","journal-title":"Cancer Res"},{"key":"1826_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.devcel.2018.08.025","volume":"47","author":"TY Feinberg","year":"2018","unstructured":"Feinberg TY, Zheng H, Liu R, Wicha MS, Yu SM, Weiss SJ. Divergent matrix-remodeling strategies distinguish developmental from neoplastic mammary epithelial cell invasion programs. Dev Cell. 2018;47:145\u201360.","journal-title":"Dev Cell"},{"key":"1826_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tcb.2008.08.007","volume":"18","author":"RG Rowe","year":"2008","unstructured":"Rowe RG, Weiss SJ. Breaching the basement membrane: who, when and how? Trends Cell Biol. 2008;18:560\u201374.","journal-title":"Trends Cell Biol"},{"key":"1826_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1042\/BST20180363","volume":"47","author":"V Gifford","year":"2019","unstructured":"Gifford V, Itoh Y. MT1-MMP-dependent cell migration: proteolytic and non-proteolytic mechanisms. Biochem Soc Trans. 2019;47:811\u201326.","journal-title":"Biochem Soc Trans"},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1083\/jcb.200108112","volume":"155","author":"T Uekita","year":"2001","unstructured":"Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol. 2001;155:1345\u201356.","journal-title":"J Cell Biol"},{"key":"1826_CR17","doi-asserted-by":"publisher","first-page":"13693","DOI":"10.1073\/pnas.241293698","volume":"98","author":"A Jiang","year":"2001","unstructured":"Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U.S.A. 2001;98:13693\u20138.","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"1826_CR18","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1242\/jcs.034561","volume":"122","author":"R Poincloux","year":"2009","unstructured":"Poincloux R, Lizarraga F, Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci. 2009;122:3015\u201324.","journal-title":"J Cell Sci"},{"key":"1826_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-cellbio-111315-125227","volume":"32","author":"A Castro-Castro","year":"2016","unstructured":"Castro-Castro A, Marchesin V, Monteiro P, Lodillinsky C, Rosse C, Chavrier P. Cellular and molecular mechanisms of MT1-MMP-dependent cancer cell invasion. Annu Rev Cell Dev Biol. 2016;32:555\u201376.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1826_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2358","volume":"11","author":"F Behbod","year":"2009","unstructured":"Behbod F, Kittrell FS, LaMarca H, Edwards D, Kerbawy S, Heestand JC, et al. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009;11:R66.","journal-title":"Breast Cancer Res"},{"key":"1826_CR21","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/cncr.10451","volume":"94","author":"I de Mascarel","year":"2002","unstructured":"de Mascarel I, MacGrogan G, Mathoulin-Pelissier S, Soubeyran I, Picot V, Coindre JM. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer. 2002;94:2134\u201342.","journal-title":"Cancer"},{"key":"1826_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10549-017-4572-2","volume":"167","author":"V Sopik","year":"2018","unstructured":"Sopik V, Sun P, Narod SA. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ. Breast Cancer Res Treat. 2018;167:787\u201395.","journal-title":"Breast Cancer Res Treat"},{"key":"1826_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","volume":"92","author":"FR Miller","year":"2000","unstructured":"Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000;92:1185\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1091\/mbc.e08-01-0016","volume":"19","author":"XY Li","year":"2008","unstructured":"Li XY, Ota I, Yana I, Sabeh F, Weiss SJ. Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase. Mol Biol Cell. 2008;19:3221\u201333.","journal-title":"Mol Biol Cell"},{"key":"1826_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ncb1616","volume":"9","author":"K Wolf","year":"2007","unstructured":"Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol. 2007;9:893\u2013904.","journal-title":"Nat Cell Biol"},{"key":"1826_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1083\/jcb.201306162","volume":"203","author":"P Monteiro","year":"2013","unstructured":"Monteiro P, Rosse C, Castro-Castro A, Irondelle M, Lagoutte E, Paul-Gilloteaux P, et al. Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia. J Cell Biol. 2013;203:1063\u201379.","journal-title":"J Cell Biol"},{"key":"1826_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/jnci\/dji143","volume":"97","author":"M Boissan","year":"2005","unstructured":"Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I, et al. Increased lung metastasis in transgenic NM23-Null\/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst. 2005;97:836\u201345.","journal-title":"J Natl Cancer Inst"},{"key":"1826_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10555-012-9374-8","volume":"31","author":"N Marino","year":"2012","unstructured":"Marino N, Nakayama J, Collins JW, Steeg PS. Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene. Cancer Metastasis Rev. 2012;31:593\u2013603.","journal-title":"Cancer Metastasis Rev"},{"key":"1826_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/labinvest.2017.105","volume":"98","author":"CY Tan","year":"2018","unstructured":"Tan CY, Chang CL. NDPKA is not just a metastasis suppressor\u2014be aware of its metastasis-promoting role in neuroblastoma. Lab Invest. 2018;98:219\u201327.","journal-title":"Lab Invest"},{"key":"1826_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121:285\u201392.","journal-title":"Br J Cancer"},{"key":"1826_CR31","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1158\/0008-5472.CAN-10-1887","volume":"70","author":"M Boissan","year":"2010","unstructured":"Boissan M, De Wever O, Lizarraga F, Wendum D, Poincloux R, Chignard N, et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res. 2010;70:7710\u201322.","journal-title":"Cancer Res"},{"key":"1826_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","volume":"13","author":"M Hu","year":"2008","unstructured":"Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008;13:394\u2013406.","journal-title":"Cancer Cell"},{"key":"1826_CR33","doi-asserted-by":"publisher","first-page":"e48741","DOI":"10.15252\/embr.201948741","volume":"21","author":"MH Kushner","year":"2020","unstructured":"Kushner MH, Ory V, Graham GT, Sharif GM, Kietzman WB, Thevissen S, et al. Loss of ANCO1 repression at AIB1\/YAP targets drives breast cancer progression. EMBO Rep. 2020;21:e48741.","journal-title":"EMBO Rep"},{"key":"1826_CR34","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1158\/0008-5472.CAN-19-0492","volume":"79","author":"I Khan","year":"2019","unstructured":"Khan I, Gril B, Steeg PS. Metastasis suppressors NME1 and NME2 promote dynamin 2 oligomerization and regulate tumor cell endocytosis, motility, and metastasis. Cancer Res. 2019;79:4689\u2013702.","journal-title":"Cancer Res"},{"key":"1826_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1091\/mbc.11.2.481","volume":"11","author":"P Nicoziani","year":"2000","unstructured":"Nicoziani P, Vilhardt F, Llorente A, Hilout L, Courtoy PJ, Sandvig K, et al. Role for dynamin in late endosome dynamics and trafficking of the cation-independent mannose 6-phosphate receptor. Mol Biol Cell. 2000;11:481\u201395.","journal-title":"Mol Biol Cell"},{"key":"1826_CR36","doi-asserted-by":"publisher","first-page":"E1872","DOI":"10.1073\/pnas.1400749111","volume":"111","author":"C Rosse","year":"2014","unstructured":"Rosse C, Lodillinsky C, Fuhrmann L, Nourieh M, Monteiro P, Irondelle M, et al. Control of MT1-MMP transport by atypical PKC during breast-cancer progression. Proc Natl Acad Sci U.S.A. 2014;111:E1872\u20139.","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"1826_CR37","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1111\/febs.12834","volume":"281","author":"M Meister","year":"2014","unstructured":"Meister M, Zuk A, Tikkanen R. Role of dynamin and clathrin in the cellular trafficking of flotillins. FEBS J. 2014;281:2956\u201376.","journal-title":"FEBS J"},{"key":"1826_CR38","doi-asserted-by":"publisher","first-page":"jcs218925.","DOI":"10.1242\/jcs.218925","volume":"131","author":"D Planchon","year":"2018","unstructured":"Planchon D, Rios Morris E, Genest M, Comunale F, Vacher S, Bieche I. et al. MT1-MMP targeting to endolysosomes is mediated by upregulation of flotillins. J Cell Sci. 2018;131:jcs218925.","journal-title":"J Cell Sci"},{"key":"1826_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1083\/jcb.150.2.377","volume":"150","author":"GC Ochoa","year":"2000","unstructured":"Ochoa GC, Slepnev VI, Neff L, Ringstad N, Takei K, Daniell L, et al. A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol. 2000;150:377\u201389.","journal-title":"J Cell Biol"},{"key":"1826_CR40","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1091\/mbc.e02-05-0308","volume":"14","author":"M Baldassarre","year":"2003","unstructured":"Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, et al. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell. 2003;14:1074\u201384.","journal-title":"Mol Biol Cell"},{"key":"1826_CR41","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/onc.2011.329","volume":"31","author":"RD Eppinga","year":"2012","unstructured":"Eppinga RD, Krueger EW, Weller SG, Zhang L, Cao H, McNiven MA. Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma. Oncogene. 2012;31:1228\u201341.","journal-title":"Oncogene"},{"key":"1826_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.devcel.2013.02.010","volume":"24","author":"GL Razidlo","year":"2013","unstructured":"Razidlo GL, Wang Y, Chen J, Krueger EW, Billadeau DD, McNiven MA. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1. Dev Cell. 2013;24:573\u201385.","journal-title":"Dev Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-01826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-01826-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-01826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T08:04:03Z","timestamp":1675325043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-01826-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":42,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,6,10]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1038\/s41388-021-01826-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}